Ultralife Corporation (ULBI)

From the record

Ultralife Corporation's filings since 2017 show 4 warning events of 2 kinds: an auditor change (8-K item 4.01, the latest 2025-08-27); a late-report notice (Form NT 10-K or NT 10-Q, 3 times, the latest 2026-03-17) (its current reports).

From the record

Ultralife Corporation's 10 filed years say what it did: revenue went from $82 million in fiscal 2016 to $191 million in fiscal 2025, up 9.8% a year; it rose in 8 of 9 years; the deepest fall was 9% from fiscal 2020 to fiscal 2021; net income was positive in 7 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Ultralife Corporation's diluted share count grew about 1.1% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 17 purchases of their own stock on the open market in the year to 2026-09-30, buying about $3 million (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Ultralife Corporation lost about 5 cents for every dollar of shareholders' money, and gross profitability: its products earned about 21 cents per dollar of everything the company owns. Leverage: it owed about 40 cents per dollar of assets, and net share issuance: its share count shrank 0.7% over the year (the filed statements).

From the record

Ultralife Corporation's standing among 39 graded names in its industry family: revenue of $191 million in fiscal 2025 ranks in the top 31% by size; a net margin of -3.1% ranks in the top 24%; revenue growth of 13.2% a year over the last 3 filed years ranks in the top 47% (its annual reports).

From the record

Ultralife Corporation's leadership, from its insiders' filings and its current reports: the chief executive on the record is Manna, Michael Edward (President and CEO, as filed), filing under that title since 2022-12-15, 3.9 years (top 46% of its family); the 4 officers and directors filing in the last fifteen months have been on the record a median of 10.2 years (top 2%); no officer or director change was reported on Form 8-K since 2023-11-13, against the 4 people in charge now (top 2%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Ultralife Corporation's room to grow, from the newest filed statements (fiscal 2025): cash of $9 million against debt of $46 million leaves -16.7% of its assets as net cash, bottom 16% of its family; cash from operations less capital spending is 3.7% of revenue (top 19%); a gross margin of 24.1% (top 50%); research spending of 5.4% of revenue (bottom 32%) (its annual report).

From the record

Ultralife Corporation's growth drivers, from the filed years to fiscal 2025: revenue grew 13.2% a year over the last three filed years against 9.8% over all 10, speeding up (top 17% of its family); the newest year grew 16.2% (top 33%); research spending grew 13.7% a year (top 38%); capital spending grew 32.1% a year (top 20%) (its annual reports). Ultralife Corporation reported 2 lines of business in fiscal 2025: Battery Energy Products at $178 million (93%), Communications Systems at $13 million (7%); 1 of 2 grew against the year before (its annual report).

From the record

Ultralife Corporation's newest year against its own record: revenue of $191 million in fiscal 2025 came in 4.1% above the $184 million its prior three years' pace pointed to (top 36% of its family); net income of $6 million against a prior three-year average of $4 million (bottom 13%); a net margin of -3.1% against 2.8% before (bottom 44%) (its annual reports).